These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 9311833

  • 1. Cre/loxP-mediated excision of a neomycin resistance expression unit from an integrated retroviral vector increases long terminal repeat-driven transcription in human hematopoietic cells.
    Fernex C, Dubreuil P, Mannoni P, Bagnis C.
    J Virol; 1997 Oct; 71(10):7533-40. PubMed ID: 9311833
    [Abstract] [Full Text] [Related]

  • 2. Transfer of single gene-containing long terminal repeats into the genome of mammalian cells by a retroviral vector carrying the cre gene and the loxP site.
    Choulika A, Guyot V, Nicolas JF.
    J Virol; 1996 Mar; 70(3):1792-8. PubMed ID: 8627702
    [Abstract] [Full Text] [Related]

  • 3. Correction of the enzyme deficiency in hematopoietic cells of Gaucher patients using a clinically acceptable retroviral supernatant transduction protocol.
    Xu L, Stahl SK, Dave HP, Schiffmann R, Correll PH, Kessler S, Karlsson S.
    Exp Hematol; 1994 Feb; 22(2):223-30. PubMed ID: 8299741
    [Abstract] [Full Text] [Related]

  • 4. High efficiency retroviral-mediated gene transduction into CD34+ cells purified from peripheral blood of breast cancer patients primed with chemotherapy and granulocyte-macrophage colony-stimulating factor.
    Lu M, Maruyama M, Zhang N, Levine F, Friedmann T, Ho AD.
    Hum Gene Ther; 1994 Feb; 5(2):203-8. PubMed ID: 7514449
    [Abstract] [Full Text] [Related]

  • 5. Stable integration of retrovirally transduced genes into human umbilical cord blood high-proliferative potential colony-forming cells (HPP-CFC) as assessed after multiple HPP-CFC colony replatings in vitro.
    Lu L, Xiao M, Clapp DW, Li ZH, Broxmeyer HE.
    Blood Cells; 1994 Feb; 20(2-3):525-30. PubMed ID: 7749119
    [Abstract] [Full Text] [Related]

  • 6. Development of high-titer retroviral producer cell lines by using Cre-mediated recombination.
    Vanin EF, Cerruti L, Tran N, Grosveld G, Cunningham JM, Jane SM.
    J Virol; 1997 Oct; 71(10):7820-6. PubMed ID: 9311869
    [Abstract] [Full Text] [Related]

  • 7. Identification of genes induced by factor deprivation in hematopoietic cells undergoing apoptosis using gene-trap mutagenesis and site-specific recombination.
    Russ AP, Friedel C, Ballas K, Kalina U, Zahn D, Strebhardt K, von Melchner H.
    Proc Natl Acad Sci U S A; 1996 Dec 24; 93(26):15279-84. PubMed ID: 8986802
    [Abstract] [Full Text] [Related]

  • 8. Excision of specific DNA-sequences from integrated retroviral vectors via site-specific recombination.
    Bergemann J, Kühlcke K, Fehse B, Ratz I, Ostertag W, Lother H.
    Nucleic Acids Res; 1995 Nov 11; 23(21):4451-6. PubMed ID: 7501469
    [Abstract] [Full Text] [Related]

  • 9. Novel integrating adenoviral/retroviral hybrid vector for gene therapy.
    Murphy SJ, Chong H, Bell S, Diaz RM, Vile RG.
    Hum Gene Ther; 2002 Apr 10; 13(6):745-60. PubMed ID: 11936973
    [Abstract] [Full Text] [Related]

  • 10. Targeted transgene insertion into the CHO cell genome using Cre recombinase-incorporating integrase-defective retroviral vectors.
    Kawabe Y, Shimomura T, Huang S, Imanishi S, Ito A, Kamihira M.
    Biotechnol Bioeng; 2016 Jul 10; 113(7):1600-10. PubMed ID: 26724679
    [Abstract] [Full Text] [Related]

  • 11. Generation of a conditionally neo(r)-containing retroviral producer cell line: effects of neo(r) on retroviral titer and transgene expression.
    Wildner O, Candotti F, Krecko EG, Xanthopoulos KG, Ramsey WJ, Blaese RM.
    Gene Ther; 1998 May 10; 5(5):684-91. PubMed ID: 9797874
    [Abstract] [Full Text] [Related]

  • 12. Highly efficient gene transfer into preterm CD34 hematopoietic progenitor cells.
    Shields LE, Kiem HP, Andrews RG.
    Am J Obstet Gynecol; 2000 Sep 10; 183(3):732-7. PubMed ID: 10992201
    [Abstract] [Full Text] [Related]

  • 13. Cre recombinase-mediated site-specific modification of a cellular genome using an integrase-defective retroviral vector.
    Huang S, Kawabe Y, Ito A, Kamihira M.
    Biotechnol Bioeng; 2010 Nov 01; 107(4):717-29. PubMed ID: 20632375
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification of genes differentially regulated by glucocorticoids and progestins using a Cre/loxP-mediated retroviral promoter-trapping strategy.
    Wan Y, Nordeen SK.
    J Mol Endocrinol; 2002 Jun 01; 28(3):177-92. PubMed ID: 12063184
    [Abstract] [Full Text] [Related]

  • 17. Mutant loxP vectors for selectable marker recycle and conditional knock-outs.
    Arakawa H, Lodygin D, Buerstedde JM.
    BMC Biotechnol; 2001 Jun 01; 1():7. PubMed ID: 11591226
    [Abstract] [Full Text] [Related]

  • 18. Cre-loxP-mediated DNA flip-flop in mammalian cells leading to alternate expression of retrovirally transduced genes.
    Kano M, Igarashi H, Saito I, Masuda M.
    Biochem Biophys Res Commun; 1998 Jul 30; 248(3):806-11. PubMed ID: 9704009
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Self-deleting retrovirus vectors for gene therapy.
    Russ AP, Friedel C, Grez M, von Melchner H.
    J Virol; 1996 Aug 30; 70(8):4927-32. PubMed ID: 8763996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.